19363-94-1 Usage
Description
2-(2'-AMINOETHYL)-6-METHYLPYRIDINE, a chemical compound with the molecular formula C9H14N2, is a pyridine derivative characterized by the presence of a pyridine ring with a methyl and an aminoethyl group attached to it. This versatile compound serves as a crucial building block in the synthesis of pharmaceuticals, agrochemicals, and dyes, and exhibits potential applications in coordination chemistry, organic synthesis, and therapeutic interventions for various diseases.
Uses
Used in Pharmaceutical Industry:
2-(2'-AMINOETHYL)-6-METHYLPYRIDINE is used as a building block for the synthesis of various pharmaceuticals, contributing to the development of new drugs and therapeutic agents. Its unique chemical structure allows for the creation of diverse molecules with potential medicinal properties.
Used in Agrochemical Industry:
In the agrochemical sector, 2-(2'-AMINOETHYL)-6-METHYLPYRIDINE is utilized as a precursor in the synthesis of agrochemicals, such as pesticides and herbicides. Its role in these applications is to provide a stable and effective platform for the development of compounds that can protect crops and enhance agricultural productivity.
Used in Dye Industry:
2-(2'-AMINOETHYL)-6-METHYLPYRIDINE is employed as a key component in the production of dyes, where its chemical properties enable the creation of vibrant and stable colorants for various applications, including textiles, plastics, and printing inks.
Used in Coordination Chemistry:
As a ligand in coordination chemistry, 2-(2'-AMINOETHYL)-6-METHYLPYRIDINE is used to form coordination complexes with metal ions. These complexes exhibit unique properties, such as catalytic activity, magnetic behavior, and optical properties, which can be harnessed in various applications, including catalysis, sensors, and materials science.
Used in Organic Synthesis:
2-(2'-AMINOETHYL)-6-METHYLPYRIDINE serves as an intermediate in organic synthesis, where it can be further modified or transformed into a wide range of organic compounds. Its presence in these reactions allows for the synthesis of complex molecules with potential applications in various fields, such as pharmaceuticals, materials, and specialty chemicals.
Used in Biological Studies and Therapeutic Applications:
2-(2'-AMINOETHYL)-6-METHYLPYRIDINE has shown promising results in biological studies, indicating its potential as a therapeutic agent for the treatment of various diseases. Its unique chemical structure and properties make it a valuable candidate for further research and development in the field of medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 19363-94-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,3,6 and 3 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 19363-94:
(7*1)+(6*9)+(5*3)+(4*6)+(3*3)+(2*9)+(1*4)=131
131 % 10 = 1
So 19363-94-1 is a valid CAS Registry Number.
19363-94-1Relevant articles and documents
PHARMACEUTICAL COMPOUNDS
-
, (2008/12/08)
The invention provides compounds which are pyrimidines of formula (I): wherein R2 is bonded at ring position 2 and -YR1 is bonded at ring position 5 or 6, or YR1 is bonded at ring position 2 and R2 is bonded at ring position 6; R is an indol-4-yl group which is substituted at the 5- or 6-position; either: (a) Y is selected from -O-(CH2)n-, -NH-(CH2)n-,. -NHC(O)-(CH2)n and -C(O)NH-(CH2)n- wherein n is 0 or an integer of 1 to 3, and R1 is selected from an unsaturated 5- to 12-membered carbocyclic or heterocyclic group which is unsubstituted or substituted and a group -NR3R4 wherein R3 and R4, which are the same or different, are each independently selected from H, C1-C6 alkyl which is unsubstituted or substituted, C3 - C10 cycloalkyl which is unsubstituted or substituted, -C(O)R, -C(O)N(R)2 and -S(O)mR, or R3 and R4 together form, with the nitrogen atom to which they are attached, a saturated 5-, 6- or 7- membered N-containing heterocyclic group which is unsubstituted or substituted; (b) Y is a direct bond and R1 is selected from an unsaturated 5- to 12-membered carbocyclic or heterocyclic group which is unsubstituted or substituted, and a group -NR3R4 wherein R3 and R4, which are the same or different, are each independently selected from H, C1-C6 alkyl which is unsubstituted or substituted, C3-C10 cycloalkyl which is unsubstituted or substituted, -C(O)R, -C(O)N(R)2 and -S(O)mR; R is selected from H, C1-C6 alkyl, C3-C10 cycloalkyl and a 5- to 12-membered aryl or heteroaryl group, which group is unsubstituted or substituted; and m is 1 or 2; or a pharmaceutically acceptable salt thereof. These compounds are inhibitors of PO K and may thus be used to treat diseases and disorders arising from abnormal cell growth, function or behaviour associated with PB kinase such as cancer, immune disorders, cardiovascular disease, viral infection, inflammation, metabolism/endocrine function disorders and neurological disorders.
